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ABSTRACT 
Large scale surveys in mammalian tissue culture cells suggest that the protein expressed at 
the median abundance is present at 8,000 - 16,000 molecules per cell and that differences in 
mRNA expression between genes explain only 10-40% of the differences in protein levels. We 
find, however, that these surveys have significantly underestimated protein abundances and 
the relative importance of transcription. Using individual measurements for 61 housekeeping 
proteins to rescale whole proteome data from Schwanhausser et al., we find that the median 
protein detected is expressed at 170,000 molecules per cell and that our corrected protein 
abundance estimates show a higher correlation with mRNA abundances than do the 
uncorrected protein data. In addition, we estimated the impact of further errors in mRNA and 
protein abundances using direct experimental measurements of these errors. The resulting 
analysis suggests that mRNA levels explain at least 56% of the differences in protein 
abundance for the 4,212 genes detected by Schwanhausser et al., though because one major 
source of error could not be estimated the true percent contribution could be higher. We also 
employed a second, independent strategy to determine the contribution of mRNA levels to 
protein expression. We show that the variance in translation rates directly measured by 
ribosome profiling is only 12%  of that inferred by Schwanhausser et al. and that the measured 
and inferred translation rates correlate only poorly (R2=0.13). Based on this, our second 
strategy suggests that mRNA levels explain ~81% of the variance in protein levels. We also 
determined the percent contributions of transcription, RNA degradation, translation and protein 
degradation to the variance in protein abundances using both of our strategies. While the 
magnitudes of the two estimates vary, they both suggest that transcription plays a more 
important role than the earlier studies implied and translation a much smaller role. Finally, the 
above estimates only apply to those genes whose mRNA and protein expression was detected. 
Based on a detailed analysis by Hebenstreit et al., we estimate that approximately 40% of 
genes in a given cell within a population express no mRNA. Since there can be no translation 
in the absence of mRNA, we argue that differences in translation rates can play no role in 
determining the expression levels for the ~40% of genes that are non-expressed.  
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INTRODUCTION 
The protein products of genes are expressed at very different levels from each other in a 
mammalian cell. Thousands of genes are not detectably expressed. Of those that are, their 
proteins are present at levels that differ by five orders of magnitude. Cytoplasmic actin, for 
example, is expressed at 1.5 x 108 molecules per cell (Kislauskis et al. 1997), whereas some 
transcription factors are expressed at only 4 x 103 molecules per cell (Biggin 2011). There are 
four major steps that determine differences in protein expression: the rates at which genes are 
transcribed, mRNAs are degraded, proteins are translated, and proteins are degraded (Fig. 1). 
The combined effect of transcription and mRNA degradation together determines mRNA 
abundances (Fig. 1). The joint effect of protein translation and protein degradation controls the 
relative differences between mRNA and protein concentrations (Fig. 1). 
Transcription has long been regarded as a dominant step and is controlled by sequence 
specific transcription factors that differentially interact with cis-regulatory DNA regions. The 
rates of the other three steps, however, vary significantly between genes as well (Boisvert et al. 
2012; Cambridge et al. 2011; Cheadle et al. 2005; de Sousa Abreu et al. 2009; Eden et al. 
2011; Guo et al. 2010; Han et al. 2013; Hentze & Kuhn 1996; Hsieh et al. 2012; Ingolia et al. 
2011; Kristensen et al. 2013; Loriaux & Hoffmann 2013; Rabani et al. 2011; Schwanhausser et 
al. 2011; Sharova et al. 2009; Yang et al. 2003). MicroRNAs, for example, differentially interact 
with mRNAs to alter rates of RNA degradation and protein translation (Ambros 2011; Baek et 
al. 2008; Elmen et al. 2008; Gennarino et al. 2012; Guo et al. 2010; Hobert 2008; Krutzfeldt et 
al. 2005; Pillai et al. 2007; Rajewsky 2011; Selbach et al. 2008; Subtelny et al. 2014; Xiao et al. 
2007). 
To quantify the relative importance of each of the four steps, label free mass spectrometry 
methods have been developed that measure the absolute number of protein molecules 
expressed per cell for thousands of genes (Bantscheff et al. 2012; Beck et al. 2011; Maier et al. 
2009; Schwanhausser et al. 2011; Vogel et al. 2010; Vogel & Marcotte 2012). By comparing 
these data to mRNA abundance data, the relative importance of transcription and mRNA 
degradation versus protein translation and protein degradation can be determined (Maier et al. 
2009; Schwanhausser et al. 2011; Vogel & Marcotte 2012) (Fig. 1). By measuring mRNA 
degradation and protein degradation rates as well, the rates of transcription and translation can 
be additionally inferred indirectly. Using this approach to study mouse NIH3T3 fibroblasts, 
Schwanhausser et al. concluded that mRNA levels explain ~40% of the variability in protein 
levels; that the cellular abundance of proteins is predominantly controlled at the level of 
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translation; that transcription is the second largest determinant; and that the degradation of 
mRNAs and proteins play a significant but lesser role (Schwanhausser et al. 2011).  
The above work has provided critically important datasets and an initial framework for analysis. 
We noticed, however, that Schwanhausser et al.’s protein abundance estimates are mostly 
lower than established values for individual proteins in the literature and that statistical methods 
to quantitate the impact of experimental error had not been employed. We therefore set out to 
explore if we could refine the analysis of these datasets and to compare our results to those of 
Schwanhausser et al. and other system wide studies. 
 
RESULTS AND DISCUSSION 
A non-linear underestimation of protein abundances 
Our starting point was a set of published abundances of 53 mammalian housekeeping proteins, 
most of which are based on SILAC mass spectrometry or western blot data (Biggin 2011; Brosi 
et al. 1993; Gregory et al. 2002; Hanamura et al. 1998; Kimura et al. 1999; Kislauskis et al. 
1997; Princiotta et al. 2003; Wollfe 1998; Wong et al. 2011; Zeiler et al. 2012). On average 
these established estimates are 16 fold higher than those from Schwanhausser et al.’s original 
label free mass spectrometry data (Dataset S1). Once we brought this discrepancy to the 
authors’ attention, they upwardly revised their abundance estimates for all 5,028 detected 
proteins and provided western blot or Selected Reaction Monitoring (SRM) mass spectrometry 
measurements for eight polypeptides in NIH3T3 cells (see Corrigendum (Schwanhausser et al. 
2011)). However, Schwanhausser et al.’s second whole proteome abundance estimates are 
still lower than individual measurements for proteins expressed below 106 molecules per cell, 
with the lowest abundance proteins showing the largest discrepancy (Fig. 2a; Dataset S1). 
Western blot and SILAC mass spectrometry measurements show the same discrepancy versus 
the label free whole proteome data (Dataset S1). For example, for proteins expressed below 1 
million molecules per cell, the 26 SILAC measurements are a median of 2.95 fold higher than 
Schwanhausser et al.’s second estimates, and the 19 western blot measurements are 3.10 fold 
higher. This suggests that the discrepancy is not due to error in the individual measurements 
as a similar bias in two independent methods is unlikely.  
Of the 61 individual measurements of protein abundance available to us, 15 were made in 
NIH3T3 cells and 42 were made in HeLa cells. The discrepancy between Schwanhausser et 
al.’s second whole proteome abundances and these individual measurements is not due to 
differences in expression levels between HeLa and NIH3T3 cells for the following reasons. 
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One, it is unlikely that such a difference would only occur for lower abundance proteins. Two, 
five of the individual measurements for lower abundance proteins (Orc2, Orc4, HDAC3, NFkB1, 
and NFkB2) were made in NIH3T3 cells and are on average 3.7 fold higher than the second 
whole proteome estimates in this same cell line (Dataset S1). Three, later in the paper we show 
that collectively the 61 individual proteins measured have on average the same relationship in 
expression values versus all other cellular proteins in both NIH3T3 and HeLa cells. Finally, 
Schwanhausser et al.’s second estimates for RNA polymerase II and general transcription 
factors such as TFIIB and TFIIE are only 1.6 fold higher than those in yeast (Borggrefe et al. 
2001) and are 7.1 times less than those in HeLa cells (Kimura et al. 1999). Yeast cells have 
1/40th the volume, 1/200th the amount of DNA and ¼ the number of genes of NIH3T3 and HeLa 
cells (Milo et al. 2010). Two fold reductions in the concentrations of a single general 
transcription factor have, in some cases, phenotypic consequence (Aoyagi & Wassarman 
2001; Deutschbauer et al. 2005; Eissenberg et al. 2002; Kim et al. 2010). Thus, it is unlikely 
that a rapidly dividing mammalian cell could function with much larger reductions in the 
amounts of all of these essential regulators to levels close to those found in yeast.  
Correcting the non-linear bias 
Schwanhausser et al. calibrated protein abundances by spiking known amounts of protein 
standards into a crude protein extract from NIH3T3 cells and then measuring the abundances 
of several thousand proteins in the mixture by label free mass spectrometry. The 20 “spiked in” 
protein standards detected in this experiment, however, were present at the equivalent > 8.0 x 
105 molecules per cell, a level that represents only the most highly expressed 11% of the 
proteins detected (Fig. 3a) (M. Selbach, personal communication (Schwanhausser et al. 
2011)). To convert mass spectrometry signals to protein abundances, Schwanhausser et al. 
assumed that a linear relationship defined using the 20 “spiked in” standards holds true for 
proteins at all abundances (Fig. 3a). The discrepancy between the resulting estimates and 
individual protein measurements, however, suggests that this assumption is not valid. We 
therefore employed the 61 individual protein measurements from the literature as they span a 
much wider abundance range. In a plot of these data vs Schwanhausser et al.’s second whole 
proteome estimates, we found that a two-part linear regression gave a statistically better fit 
over a single regression (Fig. 3b and c) (p-value=0.002, Materials and Methods). We then used 
this two-part regression to derive new abundance estimates for all 5,028 proteins in 
Schwanhausser et al.’s dataset (Dataset S1). As Figure 2b shows, the correction removes the 
non-linear bias. 
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In our rescaled data, the median abundance protein is present at 170,000 molecules per cell 
(Fig. 2b), considerably higher than Schwanhausser et al.’s original estimate of 16,000 
molecules per cell and significantly above their second estimate of 50,000 molecules per cell. 
For low abundance proteins the effect is larger. In our corrected data, the median sequence 
specific transcription factor is present at 71,000 molecules per cell versus Schwanhausser et 
al.’s estimates of first 3,500 then 9,300 molecules per cell (Dataset S1). Our correction reduces 
the range of detected abundances by ~50 fold (unlogged) compared to Schwanhausser et al.’s 
second estimates (Dataset S1) and the variance in protein levels from 0.97 (log10) to 0.36 
(log10).  
Corrected protein abundances show an increased correlation with mRNA abundances 
As an independent check on the accuracy of our corrected abundances, we compared them to 
Schwanhausser et al.’s RNA-Seq mRNA expression data. Our corrected protein abundances 
correlate more highly with mRNA abundances than do Schwanhausser et al.’s second whole 
proteome estimates (compare Fig. 4a and b). The increase in correlation coefficient is highly 
significant (p-value<10-29) (Materials and Methods), arguing that our non-linear correction to the 
whole proteome abundances has increased the accuracy of these estimates. The most 
dramatic change is that the scatter about the line of best fit is reduced and shows a stronger 
linear relationship. The 50% prediction band shows that prior to correction the half of proteins 
whose abundances are best predicted by mRNA levels are expressed over an 11 fold range 
(unlogged), but after correction they are expressed over a narrower, 4 fold range (Fig. 4a and 
b). The correction reduces the width of the 95% prediction band even further, by 18 fold.  
For our corrected data, the median number of proteins translated per mRNA is 9,800 compared 
to Schwanhausser et al.’s original estimate of 900 and their second estimate of 2,800. In yeast, 
the ratio of protein molecules translated per mRNA is 4,200 - 5,600 (Ghaemmaghami et al. 
2003; Lu et al. 2007). Given that mammalian cells have a higher protein copy number than 
yeast (Milo et al. 2010), it is not unreasonable that the ratio in mammalian cells would be the 
higher. 
 
Estimating the impact of molecule specific measurement error 
In addition to the above general error in scaling protein abundances, there are additional 
sources of experimental error that uniquely affect data for each protein and mRNA differently. 
As a result of these molecule specific measurement errors, the coefficient of determination 
between measured mRNA and measured protein levels—i.e. R2 shown in Fig. 4b—is lower 
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than the actual value between true protein and true mRNA levels. With an accurate estimate of 
the errors, it is possible to calculate the increased correlation expected between true protein 
and true mRNA abundances. Because the variance in the residuals in Fig. 4b (i.e. the 
displacement along the y axis of data points about the line of best fit) is composed of both 
experimental error and the genuine differences in the rates of translation and protein 
degradation between genes, once the experimental error has been estimated, it is also 
possible to infer the combined true effects of translation and protein degradation. 
There are two classes of molecule specific experimental error: stochastic and systematic. 
Stochastic error, or imprecision, is the variation between replica experiments and is estimated 
from this variation. Systematic error, or inaccuracy, is the reproducible under or over estimation 
of each data point, and is estimated by comparing the results obtained with the assay being 
used to those from gold standard measurements obtained with the most accurate method 
available.  
Schwanhausser et al. limited their estimation of experimental error to stochastic errors. 
Because our correction of the whole proteome abundances reduces the total variance in 
measured protein expression levels, we first reestimated the proportion of the variance in the 
residuals in Fig. 4b that is due to stochastic measurement error using replica datasets 
(Materials and Methods). We find that 7% of this variance results from stochastic protein error 
and 0.8% from stochastic mRNA error. 
Schwanhausser et al., however, also noted a significant variance between their whole genome 
RNA-Seq data and NanoString measurements for 79 genes (R2=0.79 in Fig. S8A in 
(Schwanhausser et al. 2011)), though they did not take this into account subsequently. RNA-
Seq is well known to suffer reproducible several fold biases in the number of DNA sequence 
reads obtained for different GC content genomic regions (Cheung et al. 2011; Dohm et al. 
2008). In contrast, NanoString gives an accurate measure of nucleic acid abundance as 
correlation coefficients of R2=0.99 are obtained when NanoString data are compared to known 
concentrations of nucleic acid standards (Geiss et al. 2008). Thus, it is reasonable to consider 
NanoString as a gold standard that can be used to assess the systematic error in the RNA-seq 
data by assuming that the variance between the two methods is due mostly to systematic error 
in RNA-seq. Using Analysis of Variance (ANOVA), the variance in Schwanhausser et al.’s 
NanoString/RNA-Seq comparison can be shown to be equivalent to 23.3% of the variation in 
the residuals in Fig. 4b, 29 fold larger than the stochastic component of mRNA error (see 
Materials and Methods for a discussion of the assumptions used in this analysis). 
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It is also important to assess the systematic error in the whole proteome abundances as label 
free mass spectrometry includes such biases (Bantscheff et al. 2012; Kuntumalla et al. 2009; 
Lu et al. 2007; Peng et al. 2012). In principle the “spiked in” protein standards in 
Schwanhausser et al.’s calibration experiment (i.e. the data in Fig. 3a) should provide gold 
standard data. In practice, however, the variance in mass spectrometry estimates for protein 
standards present at supposedly the same amounts is too high (i.e. the scatter along the x axis 
in Fig. 3a). This variance would contribute 61% to the variance in the residuals in Fig. 4b, yet 
the variance of the residuals between the corrected whole proteome estimates and the 61 
individual protein measurements (i.e. the scatter along the x axis about the solid red line in Fig. 
3b) would contribute only 44%. Since the western blot and SILAC methods used to make the 
61 individual protein measurements introduce some experimental error, it seems likely that the 
commercial protein standards used by Schwanhausser at al. were not as accurately prepared 
at the correct protein concentrations as one would expect. Since no other suitable gold 
standard is available, we are thus unable to estimate the systematic protein error, though it is 
likely to be less than 44% of variance in the residuals in Fig. 4b. 
Taking the stochastic protein error as a minimum estimate of protein error and the variance 
from the NanoString/RNA-Seq comparison as an estimate of all RNA errors, it can be shown 
that true mRNA levels explain at least 56% of true protein levels, and by extension protein 
degradation and translation combined explain no more than 44% (see Materials and Methods).  
Estimating the relative importance of transcription, mRNA degradation, translation and 
protein degradation 
In addition to determining protein and mRNA abundances, Schwanhausser et al. also directly 
measured mRNA and protein degradation rates and calculated the percentage that each 
contributed to the variance in protein abundances. Using this information, it is possible to 
determine the relative importance of transcription, RNA degradation, translation and protein 
degradation for different scenarios (Table 1, see Materials and Methods). For the 4,212 genes 
whose protein and mRNA expression was detected, our analysis suggests that transcription 
explains ~38% of the variance in true protein levels, RNA degradation explains ~18%, 
translation ~30%, and protein degradation ~14% (Table 1). Clearly these estimates are 
tentative and depend on the particular assumptions we have made. We believe, though, that 
they will prove more accurate than Schwanhausser et al.’s suggestion that translation is the 
predominant determinant of protein expression and that mRNA levels explain around 40% of 
the variability in protein levels (Schwanhausser et al. 2011) (Table 1).  
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Direct measurements of translation rates support our analysis 
Direct measurements of system wide translation rates using ribosome profiling (Guo et al. 
2010; Ingolia et al. 2011; Subtelny et al. 2014) provide independent evidence that translation 
rates vary less than Schwanhausser et al. suggest. The distributions of the rates of translation 
rates measured in mouse embryonic stem cells, mouse neutrophils, mouse NIH3T3 cells and 
human HeLa cells are all significantly narrower than Schwanhausser et al. inferred for mouse 
NIH3T3 cells (Fig. 5a; Table S1). For NIH3T3 cells the translation rates measured by ribosome 
profiling for 95% of the genes detected vary only 5.8 fold, but the rates inferred for 95% of 
genes by Schwanhausser et al. vary 115 fold (Fig. 5a). Because each of these datasets contain 
differing numbers of genes (Table S1), to provide a more direct comparison we took the 
intersection of genes detected by Schwanhausser et al. and by ribosome profiling in NIH3T3 
cells (Fig. 5b). The variance in measured translation rates for the genes in the intersection is 
only 12% of the variance in rates inferred by Schwanhausser et al. for these same genes (Fig. 
5b; Table S1). 
Having direct measurements of the variance in translation rates opens up a second strategy to 
estimate the relative importance of each step in gene expression (Materials and Methods). In 
our first strategy—the measured protein error strategy—protein degradation rates and errors in 
protein and mRNA abundances were determined from direct experimental data; and the 
variance in true protein levels explained by translation was inferred as that part of the variance 
in the residuals in Fig. 4b that is not explained by the three experimentally measured terms. In 
our second strategy—the measured translation strategy—translation rates, protein degradation 
rates and mRNA errors are determined from direct experimental data; and the variance in 
measured protein levels explained by protein error is inferred as that part of the variance in the 
residuals in Fig. 4a that is not explained by the sum of variances of the three experimentally 
measured components (see Materials and Methods). This measured translation strategy is thus 
independent of our rescaling of Schwanhausser et al.’s second protein abundance estimates 
and of our estimate of stochastic protein measurement error. 
According to our second strategy, for NIH3T3 cells the variance in true protein levels is 63% of 
the variance in Schwanhausser et al.’s measured protein abundances; mRNA levels contribute 
81% to the variance in true protein expression; transcription 71%; RNA degradation 10%; 
translation 11%; and protein degradation 8% (Table 1). Despite the significant differences in 
the underlying data and assumption used, these results agree broadly with those of our first 
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strategy (Table 1). Both strategies suggest that the variance in Schwanhausser et al.’s second 
protein abundance estimates is too high. Both suggest that translation contributes less to 
protein levels and that transcription contributes more that Schwanhausser et al. claimed. In 
effect, the measured rates of translation provide independent support for our rescaling of 
Schwanhausser et al.’s protein abundances and our estimates of stochastic protein error, and 
visa versa.  
Our second strategy, though, does estimate that mRNA levels and transcription explain a 
higher percent of protein expression than the first (Table 1), but this is not entirely unexpected. 
In our first strategy, we were not able to take account of systematic, molecule specific errors in 
protein abundances because appropriate control measurements were not available. Thus, this 
first strategy could well have underestimated error. In contrast, our second strategy estimates 
all types of protein abundance errors in a single term and thus has the potential to be the more 
accurate if the error in the ribosome profiling and protein degradation data is not too large.  
To further explore the relationship between our two strategies, we compared the correlation 
between translation rates inferred by Schwanhausser et al. and those measured by ribosome 
profiling in NIH3T3 cells (Fig. 6). The coefficient of determination is small (R2= 0.13), indicating 
that the ribosome profiling data explain only 13% of the variance in Schwanhausser et al.’s 
inferred rates. Considered in isolation this result does not establish if the poor correlation is due 
to errors in either or both datasets. However, our measured protein error strategy shows that 
the variance in true translation rates contributes no more than 19% to the variance in 
Schwanhausser et al.’s inferred translation rates, with the remaining 81% of the variance being 
due to experimental error (Table 1; 0.19 = (0.34x0.30)/(0.97x0.55)). The close agreement of 
this estimate with the actual correlation between measured and inferred translation rates 
(R2<=0.19 vs R2= 0.13) suggests that the poor correlation is almost entirely due to error in 
Schwanhausser et al.’s inferred rates. In addition, this result provides further evidence that our 
two strategies broadly agree, with the measured protein error strategy potentially 
underestimating the degree of error in Schwanhausser et al.’s data.  
Ribosome profiling has also shown that translation rates change only several fold upon cellular 
differentiation and, with the exception of the translation machinery, the change affects all 
expressed genes to a similar degree (Ingolia et al. 2011). Other system wide studies, including 
a separate analysis by Schwanhausser et al., also suggest that the differential regulation of 
translation may be limited to modest changes at a subset of genes (Baek et al. 2008; Hsieh et 
al. 2012; Kristensen et al. 2013; Schwanhausser et al. 2011; Selbach et al. 2008). This work 
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seems consistent with our analysis and suggests that translation may be used chiefly to fine 
tune protein expression levels. 
Estimating the number of non-transcribed genes 
Both Schwanhausser et al.’s and all of our analyses presented above consider only those 
genes whose protein and mRNA expression was detected. There are many thousands of other 
genes, however, which express no mRNA and as a result cannot be translated. To estimate the 
proportion of such genes in a typical cell, we made use of a detailed analysis by Hebenstreit et 
al, who showed that there is a trimodal distribution of mRNA expression when the data is 
derived as an average for a population of cells of a single cell type (Hebenstreit et al. 2012; 
Hebenstreit et al. 2011) (Fig. S1). The first mode contains Highly Expressed (HE) genes, 
present at one or more molecules per cell; the second mode is comprised of Low Expressed 
(LE) genes, which are not expressed in most cells but—as shown by single molecule 
fluorescent in situ hybridization—are present at one to several molecules per cell in a small 
percent of cells; and the third mode contains genes that are not detectably expressed (NE 
genes) and thus, given the assays sensitivity, are present at less than one mRNA molecule per 
100 cells. LE genes tend to be closer to HE genes on the chromosome than are NE genes, and 
it has been suggested that this proximity may allow escape from repressive chromatin 
structures in a few cells, explaining the stochastic bursts of rare transcription observed 
(Hebenstreit et al. 2012; Hebenstreit et al. 2011). 
To account for variation in the expression of individual genes between cells, which all LE genes 
at a minimum must suffer, we assume that the general distribution of mRNA expression levels 
does not vary from cell to cell even when the expression of individual genes does. The mRNA 
expression of each LE gene was divided into a component representing expression of one 
mRNA molecule in some cells and a second component representing the remaining cells that 
express no mRNA (Materials and Methods). This yields 8,763 NE and LE gene equivalents that 
are not expressed and 12,546 LE and HE gene equivalents that are expressed. For the 8,763 
non-expressed gene equivalents, the complete absence of their mRNAs from the cell means 
that they are not being translated in these cells. Therefore, there can be no variation in the 
rates at which they are translated. Instead, we assume that the absence of transcription is 
overwhelmingly the reason why these genes express no protein. 
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Implication for other system wide studies 
Two other system wide estimates of protein abundance in mammalian cells are, like 
Schwanhausser et al.’s, lower than ours. These two reports suggest that the median 
abundance protein detected is present at 8,000 (Vogel et al. 2010) or 9,700 (Beck et al. 2011) 
molecules per cell vs our estimate of 170,000 molecules per cell. Since these lower estimates 
provide less than 1/10th of the number of histones needed to cover the diploid genome with 
nucleosomes and are lower than published estimates for a wide array of other housekeeping 
proteins, it is unlikely that they are accurate. 
Another study by Wisniewski et al. provided protein abundance estimates for HeLa cells that 
are generally higher than ours and spread over a broader range (Wisniewski et al. 2012) (Fig. 
7a). These estimates are 240% higher on average than the set of individual protein 
measurements from the literature (Dataset S3, Fig. 7b). Since over 80% of these individual 
measurements were made for proteins in HeLa cells, Wisniewski et al.’s estimates must be 
incorrectly scaled. Using our two part linear regression strategy, we therefore corrected 
Wisniewski et al.’s whole proteome data (Materials and Methods, Fig. S2; Dataset S3), bringing 
the average variation between the whole proteome estimates and individual protein 
measurements to within 6% of each other (Fig. 7b; Dataset S3). Interestingly, the correction 
dramatically increases the similarity between the distributions of protein abundances in HeLa 
and NIH3T3 cells for all orthologous proteins (Fig. 7a). This establishes the important point, 
mentioned at the beginning of the Results: in aggregate the 60+ housekeeping proteins show a 
similar relationship to the expression values of all other cellular proteins in both cell lines, and 
thus the discrepancies with the uncorrected whole proteome data are not due to differences in 
expression levels in HeLa versus NIH3T3 cells. The correction also increases the correlation 
between HeLa cell protein and HeLa mRNA abundances to a statistically significant extent (p-
value, 6 x 10-20) and reduces the 50% and 95% confidence bounds for this relationship by 1.7 
fold and 4.6 fold respectively. Wisniewski et al. scaled their protein abundances using the total 
cellular protein content and the sum of the mass spectrometry signals for all detected 
polypeptides. They assumed that mass spectrometry signals are proportional to protein 
abundance. In contrast, our scaling strategy makes no such assumption and instead uses 
many individual measurements of housekeeping proteins to estimate a multipart (spline) 
function. The increased correlations obtained with individual protein measurements and with 
mRNA abundances for two cell lines suggests that our scalings are the more accurate. 
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Other estimates for the contribution of mRNA levels in determining protein expression in 
mammals are lower than ours, suggesting that mRNA levels contribute 10%-40% (Maier et al. 
2009; Vogel & Marcotte 2012). In comparison, we estimate that mRNA abundance explains 
56% - 81% for a set of 4,212 detected proteins. We also have suggested that for the 40% of 
genes in a given cell that express no mRNA, translation rates likely play no role in determining 
protein expression levels. The other groups’ neither took systematic experimental errors into 
account or made use of direct measures of translation rates and generally do not discuss non-
transcribed genes. For this reason, we suspect their analyses underestimate the contribution of 
transcription. 
CONCLUSIONS 
Quantitative whole proteome analyses can offer profound insights into the control of gene 
expression and provide baseline parameters for much of systems biology. As these important 
new technologies continue to be refined, it is critical that the data be correctly scaled, that 
experimental errors be measured and accounted for as much as possible, that all genes be 
considered, and that direct measurements of each step in gene expression be made. Additional 
measurements and controls will be needed to derive a more assured system wide 
understanding of protein and mRNA abundances and the relative importance of each of the 
four steps in gene expression. 
 
 
MATERIALS AND METHODS 
Correcting protein abundance 
For NIH3T3 cells, all credible individual protein abundance measurements available to us for 
housekeeping proteins (a total of 61 proteins, Dataset S1) were log10 transformed along with 
the corresponding estimates from Schwanhausser et al.’s second whole proteome dataset. 
Model selection of different regressive models by leave-one-out cross-validation was used to fit 
the training data (Bickel & Doksum 2001). This showed that a plausible two-part linear 
regression with a change point at 106 molecules per cell (line<1x106…slope=0.56, 
intercept=2.64; line>1x106…slope=1.06, intercept=-0.41) fit the data far better than by chance 
(likelihood ratio test bootstrap p-value=0.002 (Bickel & Doksum 2001); Fig. 3b and c). The 
resulting two-part linear model was used to correct all 5,028 protein abundance estimates (Fig. 
2b, Dataset S1). 
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The null hypothesis that the correlation coefficient of the uncorrected Schwanhausser et al. 
protein abundance estimates vs mRNA estimates (R1=0.626) is equal to that of our corrected 
protein estimates vs mRNA estimates (R2=0.642) was tested. The method for comparing 
dependent correlation coefficients (Olkin & Finn 1990) was employed because both 
correlations involve the same mRNA-seq data and it is reasonable to assume that the 
uncorrected and corrected protein abundance estimates and the mRNA estimates have a 
multivariate Gaussian distribution. The resulting two-sided p-value < 10-29 shows that R2 is 
significantly larger than R1. 
To correct protein abundance estimates for HeLa cells (Wisniewski et al. 2012), the same 
strategy used for NIH3T3 cells was used. A two-part linear regression with a change point at 
106.8 molecules per cell fit the data far better than by accident (likelihood ratio test bootstrap p-
value=0.001) (Fig. S2). The resulting two-part linear model was used to correct all HeLa cell 
protein abundance estimates (Fig. 7; Dataset S3). The correlation of HeLa cell protein 
abundance estimates with mRNA abundances was determined using the mean values of 
replica HeLa cell RNA-Seq datasets from the ENCODE consortium (Consortium 2011) (GEO 
Accession ID "GSM765402"). The hypothesis that our corrected protein abundances correlate 
more highly with these HeLa mRNA abundances than the uncorrected estimates was tested as 
above, resulting in a two sided p-value of 6 x 10-20. 
The contribution of mRNA to protein levels: measured protein error strategy 
The variance term in a linear model between measured protein abundance (MP) (response) 
and measured mRNA levels (MR) (predictor) is decomposed in a standard way (ANOVA 
(Bickel & Doksum 2001)) into three components (Fig. 8). These components of the variance in 
the residuals represent mRNA measurement error (
! 
eR ), protein measurement error (
! 
eP ), and 
the variance in a linear model between true protein abundance (TP) and true mRNA levels (TR) 
that results from the centered genuine differences in the rates of protein degradation and 
translation (PDT). The measured protein abundances considered in this case are our rescaled 
estimates.  
Statistically, we can write three linear models from Figure 8. 
    (1) 
    (2) 
    (3) ! 
TR = bRMR + cR + eR
! 
TP = bTR + c + PDT
! 
MP = TP + cP + eP
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where TR, MR, TP, MP are abundance values on a log10 scale; the three sources of variation (
! 
eR ,
! 
eP  and PDT) are assumed to be independent random variables with mean 0; the amount of 
protein degradation and translation (PDT) is taken to be independent of true mRNA levels (TR) 
on the basis of partial evidence: the variance in the residuals in Figure 4b is similar for different 
mRNA abundances; the reversal of the causal relationship between TR and MR in model (1) 
assumes that TR and MR have an approximately joint Gaussian distribution; the slope of TP in 
model (3) is assumed to be 1 because the ratios between the 61 protein published abundance 
measurements and our corrected estimates are close to 1 (Fig. 2b); and finally we note that 
implicit in the analysis of variance is the assumption that the various datasets employed can 
thought of as originating from a relatively homogeneous superpopulation. Combining (1)-(3), 
we write the linear model between measured protein abundance and measured mRNA levels 
as        (4) 
Based on model (4) 
i. We first estimated 
! 
var(beR + PDT + eP ) as 
! 
"all
2
  and 
! 
bbR   as  
! 
ˆ b all   from fitting the above 
model with the 8,424 corrected mass spec and RNA-Seq data points pooled from the two 
replicates (Dataset S1).  By independence, we have  
 
ii. We next estimated var(
! 
eR )  as  
! 
ˆ " R2   and 
! 
bR  as  
! 
ˆ b R  from fitting model (1) with the 77 
NanoString (“TR”) vs RNA-Seq (“MR”) data points, after removing two outliers (Dataset S2). 
iii. We could not estimate var(
! 
eP ) from directly fitting model (3), as TP data is not available.  As 
a surrogate, we estimated var(
! 
eP ) as 
! 
ˆ "P2  from the following linear model that quantifies the 
stochastic error in mass spec replicate data:  
   ,
 
j=1,2    (5), 
where 
! 
MPij  is the corrected mass spec data for the ith protein in the jth replicate in 
Schwanhausser et al., and 
! 
avgMPi   is the average of our corrected protein data for the ith 
protein, i = 1, …, 4,212 (Dataset S1). Please note that 
! 
ˆ "P2  is likely an underestimate of the 
protein error as we only consider the stochastic error, not the systematic error. 
iv. From the estimates 
! 
"all
2
 , 
! 
ˆ b all  , 
! 
ˆ " R2  , 
! 
ˆ b R  and 
! 
ˆ "P2   above, we estimate var(PDT) as 
! 
MP = bbRMR + bcR + c + cP + beR + PDT + eP
! 
var(beR + PDT + eP ) = b2 var(eR ) + var(PDT) + var(eP )
! 
MPij = avgMPi + (eP )ij
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Hence, we have successfully decomposed the variance estimate , i.e. the estimated 
variance of residuals between measured protein levels and measured mRNA levels, into 3 
components: 
• 
! 
ˆ " R2 —RNA error (23.3% of 
! 
"all
2 ) 
• 
! 
ˆ "P2 —protein error (7% of 
! 
"all
2 ) 
• 
! 
ˆ " PDT2 —protein degradation & translation (69.6% of 
! 
"all
2 ) 
From the diagram and the above calculation, we also derived the percentage of variability in 
the unobserved true protein levels explained by the unobserved true mRNA levels. 
   
where 
! 
ˆ " MP2  is the variance of the corrected measured protein levels. 
We separately estimated the stochastic mRNA error from the replicate RNA-Seq 
measurements of the 4,212 genes (Dataset S1). The stochastic mRNA error contributes 0.8% 
of 
! 
"all
2 .  
 
The contributions of transcription, translation and protein and mRNA degradation: 
measured  error strategy 
To determine the relative contributions of measured RNA degradation (RD) and measured 
protein degradation (PD) to the variance in true protein expression (TP), we estimated their 
variances, var(RD) and var(PD). We took Schwanhausser et al.’s calculated percentages for 
the contribution of RD and PD to explain the variance of their uncorrected mass whole 
proteome abundances (Schwanhausser et al. 2011) (6.4% for RD and 4.9% PD, Matthias 
Selbach personal communication). Since the variance of the 8,424 uncorrected mass spec 
data points from the two replicates is 0.97, we thus calculated var(RD) and var(PD) as 0.062 
and 0.048 respectively. The relative contributions of var(RD) and var(PD) to var(TP) (estimated 
as 
! 
ˆ "MP2 # ˆ "P2 ) was calculated (Table 1). We also determined the contribution of transcription 
(var(TXN)) to var(TP) as (var(TR)-var(true RD))/var(TP), where var(TR) was estimated as  
! 
ˆ "PDT2 = ˆ "all2 #
ˆ b all
ˆ b R
$ 
% 
& 
' 
( 
) 
2
ˆ "R2 # ˆ "P2
! 
ˆ " all2
! 
ˆ "MP2 # ˆ "P2 # ˆ "PDT2
ˆ "MP2 # ˆ "P2
= 55.9%
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! 
ˆ "MP2 # ˆ "P2 # ˆ "PDT2 , and the contribution of translation as (var(TP)-var(TR)-var(true PD))/var(TP) 
(Table 1).   
The contributions of each step of gene expression to protein levels: measured 
translation strategy 
We calculated the relative contributions of each of the four steps in gene expression by an 
independent, second approach that does not rely either on our rescaling of Schwanhausser et 
al.’s protein abundance estimates or on our estimate of stochastic protein errors. Instead, our 
second approach infers true protein abundance based on Subtelny et al.’s direct 
measurements of translation rates in NIH3T3 cells by ribosome profiling (Subtelny et al. 2014) 
and on our estimate of RNA measurement error. The measured protein abundances 
considered are thus Schwanhausser et al.’s second estimates, not our rescaling of these 
estimates. A central assumption is that since the variance in Subtelny et al.’s measured 
translation rates is 12% of the variance in the rates of translation inferred by Schwanhausser et 
al., then the contribution of translation to the variance in true protein levels is 12% of the value 
provided by Schwanhausser et al. 
The variance term in a linear model between measured protein abundance (MP) and measured 
mRNA levels (MR) was decomposed as before (Fig. 8) except that the variance in the linear 
model between true protein abundance (TP) and true mRNA levels (TR) that results from the 
variance in the rates of protein degradation (PD) and protein translation (PT) were considered 
separately as cPD and dPT respectively. Similar to our measured error strategy, we can write 
three linear models using the same assumptions. 
! 
TR = bRMR + cR + eR    (1) 
! 
TP = bTR + cPD+ dPT + f  (2) 
! 
MP = TP + cP + eP    (3) 
Thus, we can write the linear model between measured protein abundance (MP) and measured 
mRNA levels (MR) for the measured translation strategy as 
! 
MP = bbRMR + bcR + f + cP + beR + cPD+ dPT + ep     (4) 
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Based on this revised model (4) 
i. We first estimated
! 
var(beR + cPD+ cPT + eP )  as 
! 
ˆ "all2  and 
! 
bbR  as 
! 
ˆ b all  from fitting the above 
model with the 8,424 mass spec and RNA-Seq data points pooled from the two replicates 
using Schwanhausser’s second estimates (Dataset S1).  By independence, we thus have 
! 
var(beR + cPD+ cPT + eP ) =
! 
b2 var(eR ) + var(cPD) + var(dPT) + var(eP ) 
ii. The values of 
! 
var(eR )  and 
! 
bR  are the same as those derived previously by our measured 
error strategy. Thus, we can estimate 
! 
ˆ b = ˆ b all ˆ b R  
iii. We used the estimate of 
! 
var(cPD) from Schwanhausser et al., i.e., 0.97 x 5% = 0.0475. 
iv. From Schwanhausser et al.’s results, we have 
! 
var(dPT) = d2 var(PT) estimated as 0.97 x 
55% = 0.54. From Schwanhausser et al.’s estimates for each of 3,633 genes (Dataset S1, 
second tab, column AG) 
! 
var(PT) has an estimate of 0.29.  Hence, the estimate of 
! 
d2 is 
1.86.  From Subtelny et al., we have a separate, directly measured estimate of 
! 
var(PT) as 
0.03533, which we obtained by slightly increasing the variance of their data for the 3,126 
genes in the intersected dataset (Fig. 5B; Table S1) by the ratio of the variances for 
Schwanhausser et al.’s inferred rates for the 3,633 genes and the 3,126 genes (Table S1). 
Using this value to replace that of Schwanhausser et al., we obtained a new estimate of 
! 
var(dPT) = d2 var(PT) as 1.86 x 0.03533 = 0.06593132. 
v. Now we can estimate 
! 
var(eP )  as 
! 
ˆ " P2 = ˆ " all2 # ˆ b ˆ " R2 # ˆ " cPD2 # ˆ " dPT2  where 
! 
ˆ " cPD2  is an estimate of 
var(cPD) and 
! 
ˆ " dPT2  an estimate of var(dPT).  
vi.   Given Schwanhausser et al.’s second 8,424 uncorrected mass spec data, we can also 
estimate var(TP) as 
! 
ˆ "TP2 = ˆ "MP2 # ˆ "P2  , where 
! 
ˆ " MP2  is an estimate of var(MP).  
Given the estimates 
! 
ˆ " cPD2  and 
! 
ˆ " dPT2  and Schwanhausser et al.’s estimate of the contribution of 
the variance in RNA degradation (defined as 
! 
ˆ " gRD2 ), we can decompose 
! 
ˆ "TP2  as: 
• variance explained by PD: 
! 
ˆ " cPD2 / ˆ "TP2   
• variance explained by PT: 
! 
ˆ " dPT2 / ˆ "TP2  
• variance explained by TR: 
! 
1" ˆ # cPD2ˆ #TP2 "
ˆ # dPT2
ˆ # TP2
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• variance explained by RD: 
! 
ˆ "gRD2 / ˆ "TP2  
• variance explained by TXN: 
! 
1" ˆ # cPD2ˆ #TP2 "
ˆ # dPT2
ˆ # TP2
"
ˆ # gRD2
ˆ #TP2  
The number of genes not transcribed in a typical cell within a population.  
To estimate the number of genes not transcribed in a typical cell within a population, we 
employed a deep RNA-Seq dataset that detected polyA+ mRNA for 15,325 protein coding 
genes in mouse Th2 cells (Hebenstreit et al. 2011). To place these abundance estimates on 
the same scale as those of Schwanhausser et al.’s data the 3,841 mRNAs expressed above 1 
RPKM (reads per kilobase of exon per million mapped reads) in common between the two 
datasets were identified. The Th2 cell data were then scaled to have the same median and 
variance for these common genes in numbers of mRNA molecules per cell (Fig. S3). Following 
Hebenstreit et al., we divided the expressed genes into 11,301 Highly Expressed (HE) genes, 
present at one or more mRNA molecule per cell, and 4,024 Low Expressed (LE) genes, 
expressed below one molecule per cell. The remaining 5,984 genes whose expression was not 
detected were designated Not Expressed (NE) genes. We then divided each LE gene into two: 
a fraction of a gene expressed at 1 molecule per cell with a weight w and a fraction of a gene 
that is not expressed in any cells with a weight 1-w. The 4,024 LE genes were thus 
decomposed into 1,245 gene equivalents expressed at 1 molecules per cell and 2,779 gene 
equivalents that are not expressed. Combining these with the 11,301 HE genes and 5,984 NE 
genes, we obtained 12,546 HE and LE expressed gene equivalents and 8,763 NE and LE non-
expressed gene equivalents. 
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Table 1. The contribution of different steps in gene expression to the variance in protein 
abundances between genes 
 
 
* In this column, the value given for Schwanhausser et al.’s 2nd data is the variance in their measured protein 
abundances; the remaining values are our estimate for the variance in true protein levels for different 
scenarios.   
a Estimates from Schwanhausser et al. based on the 4,212 genes for which NIH3T3 cell protein and mRNA 
abundance data are available.  
b Our estimates for same the 4,212 genes studied by Schwanhausser et al. after correcting the overall scaling 
of the NIH3T3 cell protein abundance data and taking several sources of molecule specific experimental errors 
into account: stochastic protein error and all mRNA errors.  
c Our estimates for same the 4,212 genes studied by Schwanhausser et al. derived using measured translation 
rates from Subtelny et al.  	  
 
 
 Percent contribution to variance in protein levels 
 
variance in 
protein 
levels(log10)* 
 
mRNA 
 
Transcription 
RNA 
degradation 
 
Translation 
Protein 
degradation 
Schwanhausser 2nd dataa 0.97 40% 34% 6% 55% 5% 
Measured protein error strategyb 0.34 56% 38% 18% 30% 14% 
Measured translation strategyc 0.61 81% 71% 10% 11% 8% 
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Figure Legends 
Figure 1: The steps regulating protein expression. The steady state abundances of mRNAs 
and proteins are each determined by their relative rates of production (i.e. transcription or 
translation) and their rates of degradation.  
 
Figure 2:  A non-linear bias in protein abundance estimates and its correction. a, The y 
axis shows the ratios of 61 individually derived protein abundance estimates each divided by 
the corresponding abundance estimate from Schwanhausser et al.’s second whole proteome 
dataset. The x axis shows the abundance estimate from Schwanhausser et al.’s second whole 
proteome dataset. The red line indicates the locally weighted line of best fit (Lowess parameter 
f=1.0), and the vertical dotted grey lines show the locations of the 1st quartile, median and 3rd 
quartile of the abundance distribution of the 5,028 proteins detected in the whole proteome 
analysis. b, The same as panel a. except that the whole proteome estimates of 
Schwanhausser et al. have been corrected using a two-part linear model and the abundances 
from the 61 individual protein measurements, see Fig. 3b.  
 
Figure 3: Calibrating absolute protein abundances. a, The relationship between iBAC mass 
spectrometry signal (x axis) and the amounts of the 20 “spiked in” protein standards (y axis) 
used by Schwanhausser et al. to calibrate their whole proteome abundances (data kindly 
provided by Matthias Selbach, Dataset S2). The line of best fit is shown (red). b, The 
relationship between individually derived estimates for 61 housekeeping proteins (y axis) and 
Schwanhausser et al.’s second whole proteome estimates (x axis). The two part line of best fit 
used to correct the second whole proteome estimates is shown (solid red line) as is the single 
linear regression (dashed red line). c, The fit of different regression models for the data in panel 
b. The y axis shows the leave-one-out cross validation root mean square error for each model. 
The x axis shows the protein abundance used to separate the data for two part linear 
regressions. The red curve shows the optimum change point for a two part linear model is at an 
abundance of ~106 molecules per cell. The dashed red horizontal line shows the root mean 
square error for the single linear regression. 
 
Figure 4: Protein abundance estimates versus mRNA abundances. a, The relationship 
between Schwanhausser et al.’s second protein abundance estimates vs mRNA levels for 
4,212 genes in NIH3T3 cells. The linear regression of the data is shown in red, the 50% 
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prediction band by dashed green lines, and the 95% prediction band by dashed blue lines. b, 
The relationship between our corrected estimates of protein abundance vs mRNA levels. The 
linear regression and prediction bands are labeled as in panel a.  
 
Figure 5: Measured versus inferred translation rates. a. The relative density of ribosomes 
per mRNA for each gene directly measured by ribosome profiling (Guo et al. 2010; Ingolia et 
al. 2011; Subtelny et al. 2013) (colored lines) compared to the translation rates for each gene 
inferred by Schwanhausser et al. (Schwanhausser et al. 2011) (black lines). The distribution of 
values from the ribosome profiling experiments was scaled proportionally to have the same 
median as that of the Schwanhausser et al. values, and the gene frequencies of the each 
distribution was normalized to have the same total. The locations of the 2.5 and 97.5 
percentiles of the two distributions for NIH3T3 cells are shown as dashed lines. b. As panel a. 
except that the data for all genes in the Schwanhausser et al. dataset are shown in the solid 
black line and data for the genes in the intersection of the Schwanhausser et al. and Subtelny 
et al.’s datasets are shown in dashed lines. The variances and numbers of genes for each 
dataset are given in Table S1.  
 
Figure 6: Correlation between measured versus inferred translation rates. The 
relationship between the measured rates of translation determined by Subtelny et al. using 
ribosome footprinting vs the inferred rates of translation determined by Schwanhausser et al for 
the same set of 3,126 genes in NIH3T3 cells, see Table S1 for further details. The units shown 
are those provided in the original datasets. The linear regression is shown.  
Figure 7: Comparison of corrected and uncorrected whole proteome abundance 
estimates. a. The distributions of protein abundance estimates for 4,680 orthologous proteins 
in NIH3T3 cells (black lines) or HeLa cells (red lines). The values from Schwanhausser et al.’s 
second estimates and Wisniewski et al.’s  estimates are shown as dashed lines. The values for 
our corrected abundance estimates are shown as solid lines. b. The ratios of HeLa cell whole 
proteome abundance estimates divided by individual measurements from the literature for 66 
proteins. Results for the original data from Wisniewski et al. (dashed line) and after these 
values have been corrected (solid line) are plotted.  The green dashed vertical line indicates a 
ratio of 1.  
Figure 8: The relationship between true and measured protein and mRNA levels 
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Figure S1: The trimodal distribution of mRNA expression levels in animal cells. The black 
curve shows the frequency distribution for 15,325 genes that give detectable polyA+ mRNA 
expression in mouse Th2 cells (Hebenstreit et al. 2012; Hebenstreit et al. 2011). The two major 
modes detected for these genes are Highly Expressed (HE) genes centered at 10 molecules of 
mRNA per cell and Low Expressed (LE) genes centered at 0.1 molecules per cell. The relative 
frequency of the remaining 5,984 Not Expressed (NE) genes is represented by the area of the 
circle. The grey curve shows the expression frequency distribution in Th2 cells of the 3,841 
genes expessed above 1 molecule per cell that are from the set of the 4,212 genes whose 
mRNA and protein abundances were detected by Schwanhausser et al. All data has been 
scaled as described in the Materials and Methods and Figure S3. 
 
Figure S2. Calibrating absolute protein abundances in HeLa cells. a, The relationship 
between individually derived estimates for 66 housekeeping proteins (y axis) and Wisniewski et 
al.’s whole proteome estimates from HeLa cells (x axis) (Dataset S3). The two part line of best 
fit used to correct the whole proteome estimates is shown (solid red line) as is the single linear 
regression (dashed red line). b, The fit of different regression models for the data in panel a. 
The y axis shows the leave-one-out cross validation root mean square error for each model. 
The x axis shows the protein abundance used to separate the data for two part linear 
regressions. The red curve shows the optimum change point for a two part linear model is at an 
abundance of ~106.8 molecules per cell. The dashed red horizontal line shows the root mean 
square error for the single linear regression. 
 
Figure S3. Scaling Hebenstreit et al.’s mRNA abundances. The distribution of mRNA 
abundnaces from three datasets are shown. The 3,841 mRNAs expressed above 1 RPKM in 
the Hebenstreit et al. RNA-Seq data that are in common with mRNAs detected by 
Schwanhausser et al were identified (dashed red line). These abundances were then scaled to 
have the same median and variance as Schwanhausser et al.’s data (solid red line). This 
scaling was in addition applied to all other genes in the Hebenstreit et al. data and the resulting 
values used in the simulation shown in Figure 6 and in the mRNA expression distribution 
shown in Figure S1. 
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Table S1. Variances in translation rates estimates 
 
Cell line Dataset # genes variance* 
NIH3T3, mouse Inferred, Schwanhausser alla 3,633 0.2872103 
NIH3T3, mouse Inferred, Schwanhausser intersectb 3,126 0.2739192 
NIH3T3, mouse Ribo FP, Subtelnyc 6,012 0.04070817 
NIH3T3, mouse Ribo FP, Subtelny intersectd 3,126 0.03374892 
Neutrophil, mouse Ribo FP, Guoe 5,796 0.04145488 
HeLa, mouse Ribo FP, Guoe 5,742 0.08086076 
ES, mouse Ribo FP, Ingoliaf 10,217 0.06213300 
 
* Replica data is available for all genes used for the NIH3T3 datasets. In these cases, the means of each pair of 
measurements was calculated and the variance of these means is given. The data for Schwanhausser et al. is from 
Dataset S1. The data for Subtelny et al. is the miR-155 and miR-1 NIH3T3 cell line data from GEO GSE52809. For 
other cell lines only a single dataset is available, and thus the variance in the single gene measurements was 
determined.  
a Data from Schwanhausser et al., 2011 for which translation rates were determined for both replicas.  
b Data from Schwanhausser et al., 2011 for the intersection of genes in dataset a. and all genes detected by Subtelny 
et al. 
c Data from Subtelny et al., 2014 for genes detected at >= 10 RPKM for mRNA seq and ribosome footprints.  
d Data from Subtelny et al., 2014 for the intersection of genes in dataset a. and all genes detected by Subtelny et al. 
e Data from Guo et al., 2010 for all genes detected at >100 reads in both mRNA-seq and ribosome footprints. 
f Data from Ingolia et al., 2011 for all genes reported.  
 
 
 
  
